ITGAX and colitis: RG and fRG also alleviated the EC- or IS-induced colitis in mice; they suppressed the EC-induced myeloperoxidase activity, NF-κB activation, and TNF-α and IL-6 expression, and NF-κB+/CD11c+ cell population in the colon.